IRIS
COLOMBO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.137
NA - Nord America 3.667
SA - Sud America 932
EU - Europa 770
AF - Africa 102
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.614
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.556
SG - Singapore 2.563
BR - Brasile 765
CN - Cina 709
VN - Vietnam 394
IE - Irlanda 184
FI - Finlandia 157
HK - Hong Kong 105
IN - India 76
IT - Italia 75
DE - Germania 71
GB - Regno Unito 67
AR - Argentina 61
BD - Bangladesh 50
FR - Francia 46
MX - Messico 45
CA - Canada 34
IQ - Iraq 32
TR - Turchia 30
ZA - Sudafrica 28
PK - Pakistan 26
RU - Federazione Russa 24
PL - Polonia 23
SE - Svezia 23
UA - Ucraina 23
EC - Ecuador 21
NL - Olanda 20
CO - Colombia 19
JP - Giappone 19
VE - Venezuela 19
CL - Cile 16
PY - Paraguay 16
ID - Indonesia 15
MA - Marocco 15
UZ - Uzbekistan 14
KE - Kenya 13
ES - Italia 12
AE - Emirati Arabi Uniti 10
JO - Giordania 10
NG - Nigeria 10
PH - Filippine 10
TW - Taiwan 8
AL - Albania 7
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
MY - Malesia 6
OM - Oman 6
PE - Perù 6
SA - Arabia Saudita 6
UY - Uruguay 6
CR - Costa Rica 5
ET - Etiopia 5
RO - Romania 5
AT - Austria 4
AU - Australia 4
CY - Cipro 4
GE - Georgia 4
HN - Honduras 4
IL - Israele 4
JM - Giamaica 4
KZ - Kazakistan 4
LT - Lituania 4
PA - Panama 4
PS - Palestinian Territory 4
BE - Belgio 3
BO - Bolivia 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
KG - Kirghizistan 3
LB - Libano 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AM - Armenia 2
AO - Angola 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GH - Ghana 2
HU - Ungheria 2
NP - Nepal 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CM - Camerun 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
Totale 9.598
Salva come PNG Salva come JPEG
Città #
Singapore 1.020
Ashburn 883
San Jose 586
The Dalles 454
Shanghai 363
New York 214
Boardman 206
Dallas 187
Dublin 183
Helsinki 157
Ho Chi Minh City 134
Beijing 113
Hanoi 109
Hong Kong 97
Los Angeles 81
São Paulo 77
Seattle 39
Chandler 38
Santa Clara 38
Wilmington 23
Council Bluffs 21
Warsaw 21
Brasília 18
Brooklyn 18
Chennai 18
Johannesburg 18
Phoenix 18
Rio de Janeiro 18
Assago 16
Curitiba 16
Pune 16
Tokyo 16
Mexico City 15
Da Nang 14
London 14
Montreal 14
Baghdad 12
Nairobi 12
Atlanta 11
Boston 11
Frankfurt am Main 11
Porto Alegre 11
Can Tho 10
Chicago 10
Haiphong 10
Manchester 10
Orem 10
Quito 10
Tashkent 10
Amsterdam 9
Ankara 9
Benin City 9
Guarulhos 9
Reston 9
San Francisco 9
San Mateo 9
Stockholm 9
Buenos Aires 8
Hillsboro 8
Hải Dương 8
Manaus 8
Moscow 8
Naples 8
Recife 8
Toronto 8
Uberlândia 8
Belo Horizonte 7
Bến Tre 7
Campo Grande 7
Santiago 7
Amman 6
Baku 6
Caxias do Sul 6
Düsseldorf 6
Guangzhou 6
Kyiv 6
Lauterbourg 6
Munich 6
Muscat 6
Natal 6
Osasco 6
Paris 6
Rome 6
Santo Domingo 6
Sorocaba 6
Turin 6
Ann Arbor 5
Blumenau 5
Denver 5
Dhaka 5
Fortaleza 5
Ipatinga 5
Istanbul 5
Kuala Lumpur 5
Lahore 5
Marília 5
Milan 5
Montevideo 5
Phủ Lý 5
Praia Grande 5
Totale 5.749
Salva come PNG Salva come JPEG
Nome #
A Propensity Score Matched Comparative Study Between Paclitaxel-Coated Balloon and Everolimus-Eluting Stents for the Treatment of Small Coronary Vessels 93
Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation 89
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 87
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 82
12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry 79
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 77
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 77
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 76
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 71
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 70
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 69
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions 68
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 67
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 66
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 64
[40 Years of coronary angioplasty: success comes from skills and determination!] 63
Advances in percutaneous interventional therapies: The tricuspid valve 62
Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis 62
Acute and long-term (2-years) clinical outcomes of the CoreValve 31 mm in large aortic annuli: A multicenter study 62
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 61
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 60
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 60
A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention 58
A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis 58
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 57
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials 56
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli The TAVI-SMALL Registry 56
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm 56
Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation 54
A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization 54
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 53
6 Months’ Follow-Up of the First-in-Man Implantation of a Novel Tricuspid Flow Optimizer 53
Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials 52
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 52
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 52
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 51
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 51
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 50
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 50
A Fully Percutaneous Transeptal Transcatheter Mitral Valve Replacement With a Novel Device 50
The coronary sinus reducer: clinical evidence and technical aspects 49
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 49
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation 49
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 49
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 48
Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions 48
Mechanism and Implications of the Tricuspid Regurgitation: From the Pathophysiology to the Current and Future Therapeutic Options 48
Repeat MitraClip for early recurrent mitral regurgitation 48
Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: Insight from the Italian CoreValve Registry 48
Intraarterial thrombolysis for treatment of peripheral graft thrombosis: advantage of the radial approach 47
Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: Early results of the feasibility trial 47
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 47
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry 47
Ultrasound-accelerated thrombolysis and extracorporeal membrane oxygenation in a patient with massive pulmonary embolism and cardiac arrest 47
State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey 47
Procedural and Long-Term Outcomes of Percutaneous Coronary Intervention for In-Stent Chronic Total Occlusion 47
Which is the best anti-aggregant or anti-coagulant therapy after TAVI? A propensity matched analysis from the ITER registry. The management of DAPT after TAVI 47
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris 46
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 46
Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique 46
Prognostic value of tricuspid regurgitation 46
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System 46
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry 46
Feasibility of ultra-low contrast 64-slice computed tomography angiography before transcatheter aortic valve implantation: A real-world experience 46
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 45
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 45
First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease 45
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience 45
Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals 45
Hypertrophic Left Ventricle With Small Cavity and Severe Aortic Angulation: A Dangerous Association in Case of Transcatheter Aortic Valve Replacement 45
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 45
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 45
How should i treat recurrent restenosis with underexpanded multilayered struts after repeated complex bifurcation stenting? 44
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 44
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock 44
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 44
Prolonged Ultrasound-Assisted Catheter-Directed Low-Dose Thrombolysis for Acute Pulmonary Embolism Unresponsive to Systemic Thrombolysis 44
Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial? 43
Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study 43
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 43
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 43
Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound 43
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights 43
The Evolution From Surgery to Percutaneous Mitral Valve Interventions The Role of the Edge-to-Edge Technique 43
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom 43
Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial Club 43
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation 42
Key Imaging Factors for Transcatheter Management of Tricuspid Regurgitation: Device and Patient Selection 42
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 42
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 42
Coronary sinus Reducer non-responders: insights and perspectives 42
Prognostic implications of the relationship between effective regurgitant orifice area and left ventricle end diastolic volume in patients with functional mitral regurgitation treated with MitraClip 42
Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study 42
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 42
Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve Implantation 42
Dual Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation: Insights From the Milan Cohort 42
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis 42
ONE-YEAR CLINICAL OUTCOMES FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) WITH BOTH EDWARDS SAPIEN AND COREVALVE DEVICES IN A SINGLE CENTER: THE MILAN EXPERIENCE 41
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 41
New therapeutic options for the treatment of tricuspid regurgitation 41
Totale 5.214
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.583
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/202222 1 0 0 6 0 0 1 5 0 1 7 1
2022/2023402 9 4 8 24 22 11 2 10 48 38 208 18
2023/20241.691 107 80 389 140 131 315 79 73 26 55 134 162
2024/20252.327 71 5 7 37 53 308 162 129 466 623 256 210
2025/20265.350 917 412 276 501 215 318 1.875 228 346 262 0 0
Totale 9.830